Plerixafor and Filgrastim XM02 (Tevagastrim
®) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Plerixafor and Filgrastim XM02 (Tevagastrim ®) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation'. Together they form a unique fingerprint.